Inspiration Healthcare Group (IHC) Q4 2026 TU earnings summary

Executive summary

• Achieved strong H2 trading with revenue of £23.5 million, up 10.3% year-on-year, and full-year revenue growth of 24.0% to £47.5 million for FY26.

• Adjusted EBITDA expected to be in line with consensus market expectations, reflecting improved operational execution.

• Sales momentum is expected to continue into FY27, supported by a robust pipeline and strategic initiatives.

Financial highlights

• FY26 revenue increased by 24% to £47.5 million, slightly ahead of consensus expectations.

• Adjusted EBITDA anticipated to meet market consensus of £2.8 million.

• Net debt reduced by 39% to £5.1 million as of 31 January 2026.

Outlook and guidance

• Strong sales pipeline and momentum expected to drive continued growth into FY27.

• Focus on increasing recurring revenues from consumables and service to enhance revenue quality.